18.02.2013 • NewsICH BeneluxICHKrahn Chemie

Krahn Chemie Acquires Dutch Chemical Distributor ICH Benelux

With its takeover of ICH Benelux, Krahn Chemie is significantly expanding its market position in the distribution of speciality chemicals.

ICH Benelux was established in 1979 with headquarters in Wormerveer, Netherlands. The company group also includes the subsidiaries Technoplan Farbtechnik in Bottrop, Germany and ICH Poland in Poznan, Poland. The ICH Group has its focus on the coatings industry which it supplies with high quality raw materials and a comprehensive range of technical services. The ICH Group has 35 employees.

The acquisition of ICH Benelux is a positive addition for Krahn Chemie in numerous ways.

It enables Krahn Chemie to develop its regional position in Belgium, the Netherlands and Luxembourg and also strengthens the sales team in the European key markets Germany and Poland.

As ICH works together with leading European producers of coating raw materials, the transaction will also enhance Krahn Chemie's existing product portfolio particularly with pigments and color solution systems.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.